Figure 2From: Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term resultsLocal control (LC) and freedom from systemic progression (FSP).Back to article page